JD Vance's "Hillbilly Elegy" ignores the real Appalachian crisis it portrays
By Mesha Maren,
Salon
| 07. 20. 2024
Image by Gage Skidmore from Flickr licensed under CC BY-SA 2.0
I started reading JD Vance's 2016 memoir "Hillbilly Elegy" on election day, 2020. I didn’t plan it this way. I’d been asked to review the film and I felt that I should read the book beforehand and Tuesday, November 3, 2020 is when the book arrived. Up until then, I had pointedly avoided reading Vance’s memoir, which is back in the news this week after Donald Trump named the now-senator from Ohio as his running mate. I didn’t need to read the book because I had my own experiences with the culture that Vance deemed to be “in crisis.” I was born and raised on top of Muddy Creek Mountain outside of Alderson, West Virginia, a town of less than a thousand people nestled into the Greenbrier River valley just southeast of the coalfields.
From the passionate response pieces that I had read, I was somewhat prepared for the eugenics-tinged genetic arguments that stain the text and the deeply clichéd tropes that strangle the film...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...